Journals / Ankara Medical Journal / 2022 / Cilt: 22 - Sayı: 2

THE ASSOCIATION BETWEEN PLATELET TO LYMPHOCYTE RATIO AND LEFT ATRIAL APPENDAGE THROMBOGENIC MILIEU IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION

Pages
260–269
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: PLR may be an independent risk factor for LAA TM in nonvalvular AF patients; however, beyond research purposes, the rather low sensitivity and specificity values must be interpreted with caution in the routine clinical setting.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: To assess the diagnostic value of platelet to lymphocyte ratio (PLR) with respect to the risk of left atrial appendage thrombogenic milieu (LAA TM) in patients with nonvalvular atrial fibrillation (AF), which has not been studied before.
📊
Key Findings & Data:Results: A total of 120 patients (59 females, mean age: 66.15 ± 10.2 years) with nonvalvular AF were included in the study.
💡
Conclusion & Impact:Conclusion: PLR may be an independent risk factor for LAA TM in nonvalvular AF patients; however, beyond research purposes, the rather low sensitivity and specificity values must be interpreted with caution in the routine clinical setting.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: To assess the diagnostic value of platelet to lymphocyte ratio (PLR) with respect to the risk of left atrial appendage thrombogenic milieu (LAA TM) in patients with nonvalvular atrial fibrillation (AF), which has not been studied before. Materials and Methods: This is a retrospective study that included consecutive patients with non-valvular AF who underwent transesophageal echocardiography (TEE) prior to electrical cardioversion or prior to AF catheter ablation. The potential association between PLR and LAA TM, which was defined as the presence of a thrombus, sludge and spontaneous echo contrast in LAA, was analyzed using multivariate logistic regression analysis. Results: A total of 120 patients (59 females, mean age: 66.15 ± 10.2 years) with nonvalvular AF were included in the study. The thrombogenic milieu was determined in 37 (30.83%) patients on TEE examination. Patients with LAA TM were found to have a higher mean CHA2DS2-VASc score (3.00 vs. 2.00, p=0.009), decreased LAA velocity (23.60 vs. 36.20 m/s, p=0.002) and left ventricular ejection fraction (49.70 vs. 56.90 %, p=0.010), greater left atrial diameter (4.70 vs. 4.30 cm, p= 0.001) and higher PLR value (157.91 vs. 126.13, p=0.023) compared to those without thrombogenic milieu. Only LAA velocity (OR=0.854; p=0.001) and PLR (OR=1.024; p=0.012) were found to be independently associated with LAA TM. Conclusion: PLR may be an independent risk factor for LAA TM in nonvalvular AF patients; however, beyond research purposes, the rather low sensitivity and specificity values must be interpreted with caution in the routine clinical setting.

🔖

Cite This Article

TEK, M., EFE, F. K. (2022). THE ASSOCIATION BETWEEN PLATELET TO LYMPHOCYTE RATIO AND LEFT ATRIAL APPENDAGE THROMBOGENIC MILIEU IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION. Ankara Medical Journal, Cilt: 22 - Sayı: 2, 260–269. https://ajindex.com/articles/441696

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Illien S, Maroto-Järvinen S, Von der Recke G, et al. Atrial fibrillation: relation between clinical risk factors and transoesophageal echocardiographic risk factors for thromboembolism. Heart. 2003;89(2):165-8 (doi: 10.1136/heart.89.2.165)
  2. Yarmohammadi H, Klosterman T, Grewal G, et al. Efficacy of the CHADS2 scoring system to assess left atrial thrombogenic milieu risk before cardioversion of non-valvular atrial fibrillation. Am J Cardiol.2013;112(5):678-83 (doi: 10.1016/j.amjcard.2013.04.047)
  3. Jaroch J, Kamińska-Kegel A, Brzezińska B, et al. Predictors of left atrial appendage thrombogenic milieu in patients subjected to transesophageal echocardiography prior to cardioversion of persistent atrial fibrillation. Pol Arch Med Wewn. 2016;126(1-2):25-31 (doi: 10.20452/pamw.3261)
  4. Uz O, Atalay M, Doğan M, et al. The CHA2DS2-VASc score as a predictor of left atrial thrombus in patients with non-valvular atrial fibrillation. Med Princ Pract. 2014;23(3):234-8 (doi: 10.1159/000361028)
  5. Pant R, Patel M, Garcia-Sayan E, et al. Impact of B-type natriuretic peptide level on the risk of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation: a prospective study. Cardiovasc Ultrasound. 2016 Jan 16;14:4 (doi: 10.1186/s12947-016-0047-6)
  6. Fu Y, Li K, Yang X. ABO blood groups: A risk factor for left atrial and left atrial appendage thrombogenic milieu in patients with non-valvular atrial fibrillation. Thromb Res.2017;156:45-50 (doi: 10.1016/j.thromres.2017.05.018)
  7. Osadnik T, Wasilewski J, Lekston A, et al. The platelet-to-lymphocyte ratio as a predictor of all-cause mortality in patients with coronary artery disease undergoing elective percutaneous coronary intervention and stent implantation. J Saudi Heart Assoc. 2015;27(3):144-51 (doi:10.1016/j.jsha.2015.02.004)
  8. Y Fu, K B Li, X C Yang. Relationship between red blood cell distribution width and left atrial appendage thrombogenic milieu in old patients with non-valvular atrial fibrillation. Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Dec 24;47(12):974-978 (doi:10.3760/cma.j.issn.0253-3758.2019.12.006)
  9. Klein AL, Grimm RA, Murray RD, et al. use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med. 2001;344(19):1411-20 (doi:10.1056/NEJM200105103441901)
  10. Stoddard MF, Singh P, Dawn B, Longaker RA. Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation. Am Heart J. 2003;145(4):676-8